Login

Switch On Your HIV Smarts.

Long-acting injectable PrEP study now enrolling

Long-acting injectable PrEP study now enrolling

March 20, 2017, by

Study sites across the world are testing the effectiveness of a long-acting version of cabotegravir for PrEP. Read More

Penis bacteria linked to HIV acquisition

Penis bacteria linked to HIV acquisition

March 16, 2017, by

Read why the colonies of bacteria that populate the foreskin affect HIV risk, and how circumcision modifies risk. Read More

Are serious heart problems inevitable for people with HIV? A conversation with cardiologist Priscilla Hsue

Are serious heart problems inevitable for people with HIV? A conversation with cardiologist Priscilla Hsue

March 15, 2017, by

Cardiologist Priscilla Hsue answered questions about inflammation and cardiovascular disease among people living with HIV at a recent Positive Force event. Read More

In a class of its own, “uniquely potent” HIV capsid inhibitor thwarts HIV replication

In a class of its own, “uniquely potent” HIV capsid inhibitor thwarts HIV replication

March 14, 2017, by

Promising research about a new type of HIV drug called GS-CA1, the first capsid inhibitor to enter clinical trials, was shared at CROI 2017. Read More

New antibody therapy “profoundly” successful at reducing inflammation from HIV

New antibody therapy “profoundly” successful at reducing inflammation from HIV

March 8, 2017, by

With just one dose, canakinumab reduced markers of inflammation and improved arterial function in people living with HIV. Read More